Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Recruiting Not applicable

Loop Ileostomy Closure:Stapled or Hand-sewn Anastomoses? Suture or Mesh Closure of the Stoma Site?

NCT02669992 · tracked via the Priya Life Science Sweden tracker
Phase
Not applicable
Started
2015-06
Last updated
2023-01-26

Condition(s) studied

Rectal Neoplasm

Investigational drug(s) / intervention(s)

Stapled or Hand-sewn anastomosisMesh or suture stoma site closure

Stapled or Hand-sewn anastomosis: Randomization between stapled or hand-sewn anastomosis

Mesh or suture stoma site closure: Randomization between suture or Mesh closure of the stoma site

Study summary

There are severel problems associated with the closing of a temporary loop-ileostomy after surgery for rectal cancer. The purpose of this study is to answer two questions:

1. The choice of anastomotic method - does it influence the postoperative course?
2. The use of a prophylactic mesh when closing the stoma site - will there be less hernias?

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * loop ileostomy after rectal cancer surgery * loop ileostomy closure is permitted and possible according to clinical practice Exclusion Criteria: * patient unable to understand written or oral information

Primary outcome measure(s)

  • Number of participants with postoperative bowel obstruction — 30 days
    Postoperative bowel obstruction within 30 Days, detected clinically or by the use of x-ray
  • Number of participants with postoperative stoma site hernia — 2 year
    Herni postoperatively on the site of previous stoma detected within 2 years

Trial sites (11)

FacilityCityRegionStatus
Sahlgrenska Universitetssjukhuset, Östra sjukhuset Gothenburg Sweden Recruiting
Centralsjukhuset Karlstad Karlstad Sweden Recruiting
Sunderby Sjukhus Luleå Sweden Recruiting
Lycksele lasarett Lycksele Sweden Recruiting
Norrtälje sjukhus Norrtälje Sweden Recruiting
Östersunds sjukhus Östersund Sweden Recruiting
Skellefteå lasarett Skellefteå Sweden Recruiting
Danderyds sjukhus Stockholm Sweden Recruiting
Karolinska universitetssjukhuset Stockholm Sweden Recruiting
Norrlands Universitets Sjukhus Umeå Sweden Recruiting
Region Gotland Visby Sweden Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02669992 on ClinicalTrials.gov ↗ ← All trials in Sweden